BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$2.33

From 52W high−83.14%

Volume366998.00

Market cap$185.60M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$2.33

From 52W high

−83.14%

Volume

366998.00

Market cap

$185.60M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.2x

P/E (TTM)

—

RSI (14)

19.8

MomentumView details →

1D Return

−0.22%

YTD Return

−81.94%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.2x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−56.36%

ROA (TTM)

−48.34%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+99.93%

EBITDA YoY

—

MomentumView details →

1D Return

−0.22%

YTD Return

−81.94%

1Y Return

−81.77%

RSI (14)

19.8

vs 50D SMA

−50.71%

vs 200D SMA

−71.73%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

4.69x

Quick Ratio

4.69x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.71

EPS Surprise

−24.81%

Beats (12Q)

0/12

Next Q EPS Est

−$0.67

Avg Surprise (4Q)

−48.87%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−182.11M

Op. CF (TTM)

−193.14M

Next earningsNov 11, 2026 →

Latest newsMore news →

BridgeBio Oncology Therapeutics reported financial results for the second quarter ended June 30, 2026, and provided a business update.85d ago

Similar companies

ALX Oncology Holdings Inc.ALXO Bright Minds Biosciences Inc.DRUG Invivyd, Inc.IVVD MediWound Ltd.MDWD Compugen Ltd.CGEN Akebia Therapeutics, Inc.AKBA Find similar companies →

Latest newsMore news →

BridgeBio Oncology Therapeutics reported financial results for the second quarter ended June 30, 2026, and provided a business update.85d ago